Market Overview

Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now

Share:
Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now

  • Leerink recently hosted 24 biopharmaceutical companies at a roundtable event.
  • Of the 24 companies, Leerink now rates 20 of them as Outperform.
  • Many of these 20 companies have strong potential catalysts coming relatively soon.
  • Leerink Partners recently hosted a Rare Disease Roundtable that included fireside chats with 24 biopharmaceutical companies. Following the event, analyst Joseph Schwartz released a report that included a list of 20 Outperform-rated names that attended the roundtable.

    Here’s a list of some of the potential catalysts Schwartz sees for these companies.

    Highlighted Stocks And Catalysts

  • Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR): The company is guiding conservatively for Juxtapid sales.
  • Agios Pharmaceuticals Inc (NASDAQ: AGIO): The company is seeing clinical benefit in solid tumor indications.
  • Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY): The company reports solid enrollment in APOLLO Ph. III trial and positive OLE Phase II data.
  • Related Link: Morgan Stanley Sees Drug Pricing Still An Overhang For These Names

  • Ascendis Pharma A/S (NASDAQ: ASND): The company is ramping up manufacturing ahead of Ph. III trial in growth deficiency patients.
  • BioMarin Pharmaceutical Inc. (NASDAQ: BMRN): The company has a scheduled PDUFA date of December 27.
  • Cidara Therapeutics Inc (NASDAQ: CDTX): The company is executing well on CD101 development.
  • Dicerna Pharmaceuticals Inc (NASDAQ: DRNA): A decision on the fate of DCR-MYC is expected by the end of 2016.
  • Other Names

    In addition to the specific names mentioned above, Leerink also sees potential upcoming catalysts for the following Outperform-rated names in the space:

    • Auris Medical Holding AG (NASDAQ: EARS)
    • Epizyme Inc (NASDAQ: EPZM)
    • Fate Therapeutics Inc (NASDAQ: FATE)
    • Amicus Therapeutics, Inc. (NASDAQ: FOLD)
    • Insmed Incorporated (NASDAQ: INSM)
    • ProQR Therapeutics NV (NASDAQ: PRQR)
    • Uniqure NV (NASDAQ: QURE)
    • Raptor Pharmaceutical Corp. (NASDAQ: RPTP)
    • Retrophin Inc (NASDAQ: RTRX)
    • SAGE Therapeutics Inc (NASDAQ: SAGE)
    • Acceleron Pharma Inc (NASDAQ: XLRN)
    • Zafgen Inc (NASDAQ: ZFGN)
    • Zogenix, Inc. (NASDAQ: ZGNX)

    Disclosure: The author holds no position in the stocks mentioned.

    Image Credit: Public Domain

     

    Related Articles (AEGR + AGIO)

    View Comments and Join the Discussion!

    Posted-In: BiopharmaceuticalAnalyst Color Biotech Long Ideas Top Stories Analyst Ratings Trading Ideas General Best of Benzinga

    Latest Ratings

    StockFirmActionPT
    OCGNChardan CapitalMaintains0.700
    ZMB of A SecuritiesMaintains240.0
    PTONB of A SecuritiesMaintains54.0
    IRBTB of A SecuritiesMaintains77.0
    DKSB of A SecuritiesMaintains45.0
    View the Latest Analytics Ratings
    Don't Miss Any Updates!
    News Directly in Your Inbox
    Subscribe to:
    Benzinga Premarket Activity
    Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
    Market in 5 Minutes
    Everything you need to know about the market - quick & easy.
    Fintech Focus
    A daily collection of all things fintech, interesting developments and market updates.
    Thank You

    Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com